The In Vivo and In Vitro Assessment of Pyocins in Treating <i>Pseudomonas aeruginosa</i> Infections
<i>Pseudomonas aeruginosa</i> can cause several life-threatening infections among immunocompromised patients (e.g., cystic fibrosis) due to its ability to adapt and develop resistance to several antibiotics. In recent years, <i>P. aeruginosa</i> infections has become difficul...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-10-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/11/10/1366 |